Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,040 | -16,569 | -11,359 | -5,421 | -25,110 |
| Depreciation Amortization | 2,707 | 1,773 | 1,032 | 512 | 5,820 |
| Accounts receivable | -3,001 | -2,144 | -1,038 | 101 | -1,942 |
| Other Working Capital | 1,619 | 6,105 | 1,900 | 1,664 | 900 |
| Other Operating Activity | 3,516 | 2,495 | 1,214 | 19 | 2,462 |
| Operating Cash Flow | $-15,199 | $-8,340 | $-8,251 | $-3,125 | $-17,870 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,422 | 20,422 | 12,508 | 11,647 | -12,642 |
| PPE Investments | -15,054 | -12,653 | -6,768 | -5,600 | -16,570 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 2 |
| Investing Cash Flow | $5,368 | $7,769 | $5,740 | $6,047 | $-29,210 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,149 | N/A | N/A | N/A | 3,345 |
| Debt Repayment | -284 | -173 | -116 | -72 | -159 |
| Common Stock Issued | 7,909 | 8,105 | 8,069 | 4,006 | 25,504 |
| Other Financing Activity | -9,768 | 0 | 0 | 0 | 22,000 |
| Financing Cash Flow | $5,006 | $7,932 | $7,953 | $3,934 | $50,690 |
| Beginning Cash Position | 15,044 | 15,044 | 15,044 | 15,044 | 11,440 |
| End Cash Position | 10,219 | 22,405 | 20,486 | 21,900 | 15,040 |
| Net Cash Flow | $-4,825 | $7,361 | $5,442 | $6,856 | $3,590 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,199 | -8,340 | -8,251 | -3,125 | -17,870 |
| Capital Expenditure | -15,054 | -12,653 | -6,768 | -5,600 | -16,575 |
| Free Cash Flow | -30,253 | -20,993 | -15,019 | -8,725 | -34,445 |